[Lung cancer diagnosis based on urinary modified nucleoside metabolic profiling].
To study the feasibility of modified urinary nucleosides metabolic profiling on lung cancer diagnoses. The modified urinary nucleosides metabolic profiling from 42 normal adults and 80 patients with lung cancer were determined by a coupled-column high performance liquid chromatography system. Partial least squares-discriminant analysis (PLS-DA) models were used to class differentiation between the lung cancer patients and controls and to discover potential biomarkers. The PLS-DA model results showed that there was a clear differentiation between normal adults and lung cancers patients, with the value of prediction (Q2) equals to 0.744. Modified urinary nucleosides metabolic profiling method is useful for lung cancer diagnoses.